@article{bca887d22feb48749f975814c97225db,
title = "Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy",
keywords = "Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Ductal, Breast/drug therapy, Female, Humans, Inflammatory Breast Neoplasms/drug therapy, Lapatinib, Middle Aged, Molecular Targeted Therapy, Quinazolines/administration \& dosage, Receptor, ErbB-2/genetics, Triple Negative Breast Neoplasms/drug therapy",
author = "Ali, \{Siraj M\} and Alpaugh, \{R Katherine\} and Downing, \{Sean R\} and Stephens, \{Philip J\} and Yu, \{Jian Q\} and Hong Wu and Buell, \{Jamie K\} and Miller, \{Vincent A\} and Doron Lipson and Palmer, \{Gary A\} and Ross, \{Jeffrey S\} and Massimo Cristofanilli",
year = "2014",
month = aug,
day = "1",
doi = "10.1200/JCO.2013.49.0599",
language = "English",
volume = "32",
pages = "e88--e91",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "Lippincott Williams and Wilkins",
number = "25",
}